Skitahoe, I do not believe the Shorts have an out. Their first mistake was strategic, to short a unicorn company. Not so smart. Their second mistake was to double and triple down, after DCVax-L Phase 3 clinical trial results reported landmark success and after NWBO submitted a 1.7M page MAA.